Chiome Bioscience says it announces termination of candidate antibody related joint research contract, which was signed between the co and Chugai Pharma, as the contract has expired on Dec. 31…

The possibility of a tax bill being passed has many investors and analysts forecasting 2018 to be a big year for mergers and acquisitions. Source: BioSpace

Intellia has named John Leonard, M.D., President and CEO, effective January 1, 2018. Source: BioSpace

Under terms of the deal, Boehringer has the option to acquire Autifony's Kv3.1/3.2 positive modulator platform, which includes the company's lead compound AUT00206. Source: BioSpace

Now that we've got the bad news out of the way, we’re here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months.…

Dr. Ryan becomes a Director of the Company effective immediately and will assume his responsibilities as CEO effective February 15, 2018. Source: BioSpace

The approval was based on data from the Phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program. Source: BioSpace

Amgen tapped two companies to receive its coveted 2017 Golden Ticket at LabCentral. Source: BioSpace

Bruno Strigini, the CEO of Novartis Oncology, plans to exit the company's Executive Committee by Dec. 31, 2017, and leave entirely in early 2018. Source: BioSpace

Galapagos assumes 35% of the co-promotion efforts in Germany, France, Italy, Spain, the United Kingdom, the Netherlands, Belgium, and Luxembourg. Source: BioSpace